Skip to content

Clinical trials

Phase 1 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 1 Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20051
20061
20072
20081
20097
20105
20112
20124
20131
20141
20151
20163
20172
20185
20191
20202
20216
20226
20233
20242
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated9
Recruiting4
Unknown status4
Withdrawn3
Not yet recruiting2
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Revolution Medicines, Inc.3
Syndax Pharmaceuticals3
Aeris Therapeutics2
AstraZeneca2
Global Alliance for TB Drug Development2
Guangzhou JOYO Pharma Co., Ltd2
Michael Hoelscher2
NYU Langone Health2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases67
Respiratory Tract Diseases23
Neoplasms15
Lung Neoplasms14
Carcinoma, Non-Small-Cell Lung12
Thoracic Neoplasms12
Neoplasms by Site10
Respiratory Tract Neoplasms10
Bronchial Neoplasms9
Pulmonary Disease, Chronic Obstructive9

Trials

Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.